- Home
- SELF vs ARTV Comparison
SELF vs ARTV Comparison
Compare SELF & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- ARTV
- Stock Information
- Founded
- SELF 1983
- ARTV 2019
- Country
- SELF United States
- ARTV United States
- Employees
- SELF N/A
- ARTV N/A
- Industry
- SELF Real Estate Investment Trusts
- ARTV
- Sector
- SELF Real Estate
- ARTV
- Exchange
- SELF Nasdaq
- ARTV NYSE
- Market Cap
- SELF 56.9M
- ARTV 61.9M
- IPO Year
- SELF N/A
- ARTV 2024
- Fundamental
- Price
- SELF $5.16
- ARTV $2.43
- Analyst Decision
- SELF
- ARTV Strong Buy
- Analyst Count
- SELF 0
- ARTV 7
- Target Price
- SELF N/A
- ARTV $20.00
- AVG Volume (30 Days)
- SELF 38.0K
- ARTV 683.4K
- Earning Date
- SELF 05-09-2025
- ARTV 05-22-2025
- Dividend Yield
- SELF 5.63%
- ARTV N/A
- EPS Growth
- SELF N/A
- ARTV N/A
- EPS
- SELF 0.19
- ARTV N/A
- Revenue
- SELF $12,530,280.00
- ARTV $251,000.00
- Revenue This Year
- SELF N/A
- ARTV N/A
- Revenue Next Year
- SELF N/A
- ARTV N/A
- P/E Ratio
- SELF $27.11
- ARTV N/A
- Revenue Growth
- SELF 2.79
- ARTV N/A
- 52 Week Low
- SELF $4.16
- ARTV $1.78
- 52 Week High
- SELF $5.85
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- SELF 52.12
- ARTV N/A
- Support Level
- SELF $4.79
- ARTV N/A
- Resistance Level
- SELF $5.32
- ARTV N/A
- Average True Range (ATR)
- SELF 0.18
- ARTV 0.00
- MACD
- SELF 0.02
- ARTV 0.00
- Stochastic Oscillator
- SELF 58.18
- ARTV 0.00
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).